Last Price | 10.60 | Max Price | 12.43 |
Min Price | 8.12 | 1 Year return | -6.44 |
Avg. Target | 0.00 | Expected Return | -100.00 % |
Sector | Health Care | Subsector | Health Care Eq. & Services |
Sell | 0 | Rating | |
Hold | 0 | Concensus | |
Buy | 0 |
Contact info:Country: Germany
Year | Turnover | Total sector | Market share |
---|---|---|---|
2019 | 0 | 2,019,627 | 0.00 % |
2020 | 2,621 | 2,170,562 | 0.12 % |
2021 | 3,765 | 2,404,921 | 0.16 % |
2022 | 3,251 | 2,645,840 | 0.12 % |
2023 | 0 | 0 | 0.00 % |
Date Label | Bank Label | Stock Label | Advice Label | Price Label | Diff Label |
---|---|---|---|---|---|
April 07, 2023 | Jefferies & Co. | Synlab | Hold | 9.30 | -14.62 % |
November 12, 2022 | JP Morgan | Synlab | Hold | 12.90 | 23.26 % |
November 10, 2022 | Barclays | Synlab | Buy | 24.00 | 58.83 % |
November 10, 2022 | JP Morgan | Synlab | Hold | 17.10 | 42.22 % |
September 10, 2022 | Berenberg | Synlab | Buy | 19.00 | 51.16 % |
September 19, 2021 | Deutsche Bank | Synlab | Buy | 25.00 | 40.72 % |
September 11, 2021 | Barclays | Synlab | Hold | 21.00 | 32.05 % |
September 06, 2021 | Goldman Sachs | Synlab | Buy | 23.30 | 40.34 % |
June 07, 2021 | JP Morgan | Synlab | Hold | 20.30 | 10.10 % |
June 07, 2021 | Deutsche Bank | Synlab | Buy | 24.00 | 26.38 % |
June 07, 2021 | Goldman Sachs | Synlab | Buy | 21.90 | 19.32 % |
June 07, 2021 | Jefferies & Co. | Synlab | Buy | 23.00 | 20.65 % |
No Records Found
No Records Found
No Records Found
Results |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Revenue |
0
|
0
|
0
|
0
|
0
|
2,621
|
Costs |
0
|
0
|
0
|
0
|
0
|
2,364
|
Profit |
0
|
0
|
0
|
0
|
0
|
258
|
Margin of profit |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
9.83
|
ROI |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
21.36
|
Balance |
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|---|
Equity |
0
|
0
|
0
|
0
|
0
|
1,206
|
Debt |
0
|
0
|
0
|
0
|
0
|
4,078
|
Total assets |
0
|
0
|
0
|
0
|
0
|
5,283
|
Solvency |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
22.82
|
Cash |
0
|
0
|
0
|
0
|
0
|
905
|
Cashflow |
0
|
0
|
0
|
0
|
0
|
517
|
Employees |
0
|
0
|
0
|
0
|
0
|
|
Revenue per employee |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
|
Cashflow / Debt |
0.0
|
0.0
|
0.0
|
0.0
|
0.0
|
0.13
|
Details |
2016
|
2017
|
2018
|
2019
|
2020
|
---|---|---|---|---|---|
Price |
0.0
|
0.0
|
0.0
|
0.0
|
10.60
|
Eps |
0.0
|
0.0
|
0.0
|
0.0
|
1.29
|
Price/earnings-ratio |
0.0
|
0.0
|
0.0
|
0.0
|
8.22
|
Dividend |
0.0
|
0.0
|
0.0
|
0.0
|
|
Dividend % |
0.00 %
|
0.00 %
|
0.00 %
|
0.00 %
|
|
Payout % |
0.0
|
0.0
|
0.0
|
0.0
|
|
Book value |
0.0
|
0.0
|
0.0
|
0.0
|
5.43
|
Market to book |
0.0
|
0.0
|
0.0
|
0.0
|
0.51
|
Cashflow per stock |
0.0
|
0.0
|
0.0
|
0.0
|
2.33
|
Stocks |
0
|
0
|
0
|
0
|
222
|
Market Cap |
0.00
|
0.00
|
0.00
|
0.00
|
2.355.55
|
Date
|
Price
|
---|---|
22 Apr 2024
|
10.60
|
18 Apr 2024
|
10.60
|
17 Apr 2024
|
10.66
|
09 Apr 2024
|
10.68
|
05 Apr 2024
|
10.66
|
03 Apr 2024
|
10.90
|
30 Mar 2024
|
10.95
|
22 Mar 2024
|
11.00
|
18 Mar 2024
|
11.56
|
15 Mar 2024
|
11.61
|
12 Mar 2024
|
10.87
|
11 Mar 2024
|
11.41
|
09 Mar 2024
|
11.41
|
07 Mar 2024
|
11.64
|
01 Mar 2024
|
12.43
|
29 Feb 2024
|
11.80
|
27 Feb 2024
|
11.85
|
22 Feb 2024
|
11.76
|
21 Feb 2024
|
11.85
|
20 Feb 2024
|
11.85
|
15 Feb 2024
|
11.97
|
14 Feb 2024
|
12.01
|
13 Feb 2024
|
11.93
|
09 Feb 2024
|
11.85
|
08 Feb 2024
|
11.85
|
07 Feb 2024
|
11.84
|
06 Feb 2024
|
11.91
|
05 Feb 2024
|
12.00
|
01 Feb 2024
|
11.84
|
31 Jan 2024
|
11.84
|